Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

CAMP4
One Kendall Square Bldg. 1400 West, 3rd Floor
Cambridge, MA 02139
https://www.camp4tx.com/

CAMP4's RNA Actuating Platform (RAP) maps regRNAs associated with every protein-coding gene in any cell type, and its programmable antisense oligonucleotide (ASO) therapeutics target the controlling regRNAs to upregulate gene expression to treat disease. This approach is applicable to a range of genetic diseases in which tunable increases in gene output can lead to meaningful therapeutic outcomes.

Key Contact
Name
Josh Mandel-Brehm
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
07/21/22 $100,000,000 Series B 5AM Ventures
Andreessen Horowitz
Enavate Sciences
Gaingels
Kraft Group
Northpond Ventures
Polaris Partners
undisclosed